May 31, 2016 / 10:57 PM / 2 years ago

Valeant to report first-quarter results on June 7

(Reuters) - Valeant Pharmaceuticals Inc (VRX.TO) (VRX.N), which has come under scrutiny for its business and accounting practices, said on Tuesday it would host a conference call on June 7 to discuss first-quarter results.

The Beleaguered Canadian drugmaker reiterated that it expects to file its quarterly report with U.S. and Canadian regulators on or before June 10, ahead of a July 31 deadline.

    The troubled drugmaker filed its 2015 financial report in late April, allaying concerns about a possible default on its debt of more than $30 billion.

    The company missed an original March 15 deadline, citing an in-house review of its accounting practices. The probe found problems dating back to 2014.

    Reporting by Arathy S Nair in Bengaluru

    0 : 0
    • narrow-browser-and-phone
    • medium-browser-and-portrait-tablet
    • landscape-tablet
    • medium-wide-browser
    • wide-browser-and-larger
    • medium-browser-and-landscape-tablet
    • medium-wide-browser-and-larger
    • above-phone
    • portrait-tablet-and-above
    • above-portrait-tablet
    • landscape-tablet-and-above
    • landscape-tablet-and-medium-wide-browser
    • portrait-tablet-and-below
    • landscape-tablet-and-below